Bristol Myers Squibb - 52 Year Stock Price History | BMY

Historical daily share price chart and data for Bristol Myers Squibb since 1972 adjusted for splits and dividends. The latest closing stock price for Bristol Myers Squibb as of November 08, 2024 is 54.14.
  • The all-time high Bristol Myers Squibb stock closing price was 73.93 on December 02, 2022.
  • The Bristol Myers Squibb 52-week high stock price is 56.80, which is 4.9% above the current share price.
  • The Bristol Myers Squibb 52-week low stock price is 39.35, which is 27.3% below the current share price.
  • The average Bristol Myers Squibb stock price for the last 52 weeks is 48.57.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
Bristol Myers Squibb Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2024 47.2408 50.2299 55.9500 39.0290 54.1400 10.83%
2023 58.5848 65.8478 68.4547 46.1552 48.8495 -25.49%
2022 65.6434 54.6809 73.9307 54.6809 65.5653 19.00%
2021 55.0101 52.9891 60.7434 47.3907 55.0962 2.89%
2020 51.3669 53.0089 56.4318 38.8319 53.5503 0.39%
2019 41.1920 42.0787 53.3413 35.2498 53.3413 27.86%
2018 45.8925 47.9247 54.2695 39.1333 41.7175 -12.91%
2017 44.5656 45.2381 51.0827 35.8623 47.9013 7.72%
2016 47.6300 50.0924 58.0153 37.4613 44.4695 -13.50%
2015 47.5487 43.4640 52.5552 42.3237 51.4076 19.24%
2014 37.5034 37.1326 44.4942 33.3285 43.1135 14.18%
2013 30.6149 22.5371 37.9906 22.5371 37.7577 69.95%
2012 22.3583 22.9395 24.3964 21.0032 22.2167 -3.78%
2011 18.6682 16.6231 23.1229 15.8140 23.0902 39.43%
2010 15.7608 15.4582 17.2656 13.6961 16.5606 8.74%
2009 12.6818 13.6279 15.4640 9.9926 15.2290 14.78%
2008 11.9186 14.0798 14.5917 9.7182 13.2683 -6.05%
2007 15.1323 13.6564 16.9555 13.5114 14.1224 4.75%
2006 12.1494 11.3694 13.4822 10.2512 13.4822 19.92%
2005 11.6456 11.8911 12.6592 10.2882 11.2422 -6.16%
2004 11.5572 13.2584 13.8411 10.3990 11.9799 -7.27%
2003 11.1184 10.3940 12.9196 9.1396 12.9196 29.02%
2002 12.9686 21.0718 21.2583 8.6774 10.0133 -52.36%
2001 23.4518 28.9150 28.9150 20.1940 21.0182 -29.71%
2000 23.3832 25.6336 29.9018 17.3758 29.9018 17.11%
1999 26.9738 25.6032 31.0037 22.7050 25.5341 -2.80%
1998 21.2220 18.3803 26.2707 17.4441 26.2707 42.93%
1997 14.6536 10.1994 18.9204 10.1994 18.3803 77.07%
1996 8.6040 7.8319 10.9468 7.4224 10.3804 32.15%
1995 6.2111 5.2242 7.8777 5.1471 7.8548 53.26%
1994 4.7950 4.8289 5.3007 4.3118 5.1250 6.09%
1993 4.7590 5.3048 5.3048 4.1875 4.8306 -9.48%
1992 5.5898 6.7688 6.8071 4.8654 5.3364 -21.16%
1991 5.9725 4.9556 6.7688 4.5651 6.7688 35.84%
1990 4.2999 4.0722 4.9940 3.6595 4.9831 24.56%
1989 3.4629 3.0448 4.0432 3.0187 4.0007 28.87%
1988 2.8911 2.9348 3.1214 2.6125 3.1044 9.89%
1987 3.2364 2.8625 3.7321 2.4768 2.8249 0.77%
1986 2.5679 2.2308 2.9813 2.0486 2.8032 24.71%
1985 1.9884 1.7388 2.2942 1.6879 2.2478 26.48%
1984 1.5740 1.4633 1.7812 1.4165 1.7772 23.98%
1983 1.3173 1.1366 1.6160 1.0687 1.4335 25.66%
1982 1.0083 0.8949 1.2426 0.8674 1.1408 26.57%
1981 0.8880 0.8652 0.9924 0.7826 0.9013 5.45%
1980 0.6907 0.6172 0.8716 0.5216 0.8547 36.16%
1979 0.5862 0.6043 0.6489 0.5301 0.6277 3.50%
1978 0.5713 0.5663 0.6743 0.4792 0.6065 6.31%
1977 0.5526 0.5768 0.6043 0.4898 0.5705 -1.99%
1976 0.6202 0.5874 0.7019 0.5248 0.5821 -0.36%
1975 0.5267 0.4336 0.6245 0.3997 0.5842 37.39%
1974 0.3941 0.3965 0.4761 0.2682 0.4252 8.11%
1973 0.5187 0.5810 0.6055 0.3732 0.3933 -32.80%
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $109.806B $45.006B
Bristol-Myers Squibb is a one of the leading global specialty biopharmaceutical companies focused on the development of treatments targeting serious diseases like cancer, inflammatory, immunologic, cardiovascular or fibrotic diseases. Backed by its blockbuster immuno-oncology drug, Opdivo, Bristol-Myers has a strong oncology portfolio, comprising other drugs like Revlimid, Pomalyst, Sprycel, Yervoy and Empliciti. It also has important immunology and cardiovascular drugs like Orencia and Eliquis. It's experiencing growth in both the Eliquis brand and the market, while also advancing its Factor XIa inhibitor program. After the sale of the global Diabetes business to AstraZeneca and the discontinuation of discovery research efforts in virology, it's focusing solely on research in core therapeutic areas like oncology, immuno-oncology, immunoscience, cardiovascular, fibrosis and genetically defined diseases. It acquried Celgene Corporation and MyoKardia. It received regulatory approvals for Reblozyl and Inrebic.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $174.849B 16.92
Vertex Pharmaceuticals (VRTX) United States $133.076B 0.00
Gilead Sciences (GILD) United States $120.223B 21.80
Regeneron Pharmaceuticals (REGN) United States $91.035B 20.72
CSL (CSLLY) Australia $90.547B 0.00
GSK (GSK) United Kingdom $75.213B 8.70
Alnylam Pharmaceuticals (ALNY) United States $35.783B 0.00
Argenex SE (ARGX) Netherlands $35.638B 0.00
BioNTech SE (BNTX) Germany $26.306B 0.00
Biogen (BIIB) United States $25.215B 10.83
Illumina (ILMN) United States $23.963B 87.34
BeiGene (BGNE) Cayman Islands $20.001B 0.00
Moderna (MRNA) United States $18.001B 0.00
Incyte (INCY) United States $16.063B 0.00
Genmab (GMAB) Denmark $15.274B 22.41
Vaxcyte (PCVX) United States $13.295B 0.00
Insmed (INSM) United States $13.157B 0.00
BioMarin Pharmaceutical (BMRN) United States $12.782B 29.68
Bio-Techne Corp (TECH) United States $12.069B 46.60
Sarepta Therapeutics (SRPT) United States $11.616B 104.84
Exelixis (EXEL) United States $10.352B 23.54
Revolution Medicines (RVMD) United States $10.167B 0.00
QIAGEN (QGEN) Netherlands $9.986B 20.54
Intra-Cellular Therapies (ITCI) United States $9.678B 0.00
Exact Sciences (EXAS) United States $9.528B 0.00
Bio-Rad Laboratories (BIO.B) United States $9.375B 31.86
Roivant Sciences (ROIV) United Kingdom $8.778B 0.00
Repligen (RGEN) United States $7.880B 120.26
Halozyme Therapeutics (HALO) United States $7.758B 17.52
Viking Therapeutics (VKTX) United States $7.631B 0.00
Ascendis Pharma (ASND) Denmark $7.540B 0.00
Legend Biotech (LEGN) United States $7.298B 0.00
Cytokinetics (CYTK) United States $6.822B 0.00
Blueprint Medicines (BPMC) United States $6.405B 0.00
Nuvalent (NUVL) United States $6.183B 0.00
Krystal Biotech (KRYS) United States $5.741B 95.05
Arcellx (ACLX) United States $5.540B 0.00
ADMA Biologics Inc (ADMA) United States $5.272B 56.55
Avidity Biosciences (RNA) United States $5.130B 0.00
Biohaven (BHVN) United States $5.055B 0.00
Alkermes (ALKS) Ireland $4.670B 15.68
Ultragenyx Pharmaceutical (RARE) United States $4.650B 0.00
Denali Therapeutics (DNLI) United States $4.512B 0.00
Immunovant (IMVT) United States $4.486B 0.00
CRISPR Therapeutics AG (CRSP) Switzerland $4.406B 0.00
Axsome Therapeutics (AXSM) United States $4.278B 0.00
Rhythm Pharmaceuticals (RYTM) United States $4.138B 0.00
ImmunityBio (IBRX) United States $3.880B 0.00
Merus (MRUS) Netherlands $3.731B 0.00
Apellis Pharmaceuticals (APLS) United States $3.729B 0.00
Guardant Health (GH) United States $3.535B 0.00
Edgewise Therapeutics (EWTX) United States $3.411B 0.00
Xenon Pharmaceuticals (XENE) Canada $3.409B 0.00
MoonLake Immunotherapeutics (MLTX) Switzerland $3.308B 0.00
Kymera Therapeutics (KYMR) United States $3.300B 0.00
Amicus Therapeutics (FOLD) United States $3.284B 0.00
Verona Pharma American Depositary Share (VRNA) United Kingdom $3.134B 0.00
HUTCHMED (China) (HCM) Hong Kong, SAR China $3.129B 0.00
Zai Lab (ZLAB) China $3.050B 0.00
Iovance Biotherapeutics (IOVA) United States $2.962B 0.00
ACADIA Pharmaceuticals (ACAD) United States $2.929B 22.64
Janux Therapeutics (JANX) United States $2.830B 0.00
Apogee Therapeutics (APGE) United States $2.750B 0.00
Protagonist Therapeutics (PTGX) United States $2.723B 17.38
IDEAYA Biosciences (IDYA) United States $2.704B 0.00
CG Oncology (CGON) United States $2.679B 0.00
Twist Bioscience (TWST) United States $2.660B 0.00
Vericel (VCEL) United States $2.648B 900.00
Vera Therapeutics (VERA) United States $2.637B 0.00
Geron (GERN) United States $2.562B 0.00
Keros Therapeutics (KROS) United States $2.548B 0.00
SpringWorks Therapeutics (SWTX) United States $2.525B 0.00
Belite Bio (BLTE) United States $2.482B 0.00
Akero Therapeutics (AKRO) United States $2.392B 0.00
Scholar Rock Holding (SRRK) United States $2.327B 0.00
Longboard Pharmaceuticals (LBPH) United States $2.327B 0.00
Bavarian Nordic (BVNRY) Denmark $2.324B 12.44
Beam Therapeutics (BEAM) United States $2.241B 0.00
Ligand Pharmaceuticals (LGND) United States $2.215B 57.19
Structure Therapeutics (GPCR) United States $2.175B 0.00
Neumora Therapeutics (NMRA) United States $2.167B 0.00
Fortrea Holdings (FTRE) United States $2.106B 67.14
Harmony Biosciences Holdings (HRMY) United States $2.058B 17.10
WAVE Life Sciences (WVE) Singapore $2.051B 0.00
NeoGenomics (NEO) United States $2.024B 0.00
MannKind (MNKD) United States $2.020B 52.46
Spyre Therapeutics (SYRE) United States $2.015B 0.00
Mirum Pharmaceuticals (MIRM) United States $2.004B 0.00
Nurix Therapeutics (NRIX) United States $1.937B 0.00
Disc Medicine (IRON) United States $1.932B 0.00
NovoCure (NVCR) Jersey $1.887B 0.00
Tarsus Pharmaceuticals (TARS) United States $1.880B 0.00
Arvinas (ARVN) United States $1.865B 0.00
Syndax Pharmaceuticals (SNDX) United States $1.862B 0.00
Galapagos (GLPG) Belgium $1.783B 0.00
Certara (CERT) United States $1.776B 50.14
Celldex Therapeutics (CLDX) United States $1.740B 0.00
Immunocore Holdings (IMCR) United Kingdom $1.735B 0.00
Dynavax Technologies (DVAX) United States $1.705B 100.08
Intellia Therapeutics (NTLA) United States $1.699B 0.00
Day One Biopharmaceuticals (DAWN) United States $1.653B 0.00
Kiniksa Pharmaceuticals (KNSA) United Kingdom $1.651B 0.00
Arcus Biosciences (RCUS) United States $1.633B 0.00
Viridian Therapeutics (VRDN) United States $1.611B 0.00
Rocket Pharmaceuticals (RCKT) United States $1.588B 0.00
Myriad Genetics (MYGN) United States $1.581B 0.00
Travere Therapeutics (TVTX) United States $1.549B 0.00
Praxis Precision Medicines (PRAX) United States $1.451B 0.00
Gyre Therapeutics (GYRE) United States $1.431B 0.00
Novavax (NVAX) United States $1.426B 0.00
Kura Oncology (KURA) United States $1.355B 0.00
Upstream Bio (UPB) United States $1.344B 0.00
Vir Biotechnology (VIR) United States $1.322B 0.00
ANI Pharmaceuticals (ANIP) United States $1.293B 17.60
Arcutis Biotherapeutics (ARQT) United States $1.266B 0.00
Bicara Therapeutics (BCAX) United States $1.233B 0.00
Bicycle Therapeutics (BCYC) United Kingdom $1.186B 0.00
Applied Therapeutics (APLT) United States $1.159B 0.00
ArriVent BioPharma (AVBP) United States $1.148B 0.00
Zymeworks (ZYME) United States $1.145B 0.00
Cogent Biosciences (COGT) United States $1.117B 0.00
MiMedx (MDXG) United States $1.107B 28.96
Immatics (IMTX) Germany $1.104B 0.00
Septerna (SEPN) $1.088B 0.00
Mesoblast (MESO) Australia $1.048B 0.00
89BIO (ETNB) United States $1.028B 0.00
CARGO Therapeutics (CRGX) United States $1.026B 0.00
Phathom Pharmaceuticals (PHAT) United States $1.005B 0.00
Autolus Therapeutics (AUTL) United Kingdom $0.993B 0.00
Rapport Therapeutics (RAPP) United States $0.976B 0.00
LENZ Therapeutics (LENZ) United States $0.964B 0.00
Prothena (PRTA) Ireland $0.952B 0.00
Castle Biosciences (CSTL) United States $0.932B 166.45
Cullinan Therapeutics (CGEM) United States $0.929B 0.00
Cytek Biosciences (CTKB) United States $0.927B 0.00
Pliant Therapeutics (PLRX) United States $0.912B 0.00
Erasca (ERAS) United States $0.887B 0.00
Neurogene (NGNE) United States $0.886B 0.00
Adaptive Biotechnologies (ADPT) United States $0.858B 0.00
Dianthus Therapeutics (DNTH) United States $0.853B 0.00
Tyra Biosciences (TYRA) United States $0.851B 0.00
Replimune (REPL) United States $0.850B 0.00
Liquidia Technologies (LQDA) United States $0.847B 0.00
Zenas BioPharma (ZBIO) United States $0.836B 0.00
AbCellera Biologics (ABCL) Canada $0.797B 0.00
Pacira BioSciences (PCRX) United States $0.796B 7.50
Anavex Life Sciences (AVXL) United States $0.784B 0.00
Avid Bioservices (CDMO) United States $0.782B 0.00
Immunome (IMNM) United States $0.780B 0.00
IGM Biosciences (IGMS) United States $0.773B 0.00
Annexon (ANNX) United States $0.764B 0.00
BioAge Labs (BIOA) United States $0.758B 0.00
Entrada Therapeutics (TRDA) United States $0.742B 12.47
Stoke Therapeutics (STOK) United States $0.735B 0.00
MBX Biosciences (MBX) United States $0.730B 0.00
Oric Pharmaceuticals (ORIC) United States $0.724B 0.00
Nuvation Bio (NUVB) United States $0.718B 0.00
Arbutus Biopharma (ABUS) United States $0.711B 0.00
Olema Pharmaceuticals (OLMA) United States $0.710B 0.00
CorMedix Inc (CRMD) United States $0.704B 0.00
Mineralys Therapeutics (MLYS) United States $0.698B 0.00
Y-mAbs Therapeutics (YMAB) United States $0.690B 0.00
Humacyte (HUMA) United States $0.690B 0.00
Sana Biotechnology (SANA) United States $0.669B 0.00
Astria Therapeutics (ATXS) United States $0.667B 0.00
Abivax SA (ABVX) France $0.663B 0.00
Oculis Holding AG (OCS) Switzerland $0.659B 0.00
AnaptysBio (ANAB) United States $0.648B 0.00
Tectonic Therapeutic (TECX) United States $0.648B 0.00
Sinovac Biotech (SVA) China $0.645B 0.00
Allogene Therapeutics (ALLO) United States $0.644B 0.00
CureVac (CVAC) Germany $0.636B 0.00
Emergent Biosolutions (EBS) United States $0.623B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.622B 0.00
Third Harmonic Bio (THRD) United States $0.616B 0.00
Mind Medicine (MindMed) (MNMD) United States $0.613B 0.00
Sangamo Therapeutics (SGMO) United States $0.598B 0.00
Corvus Pharmaceuticals (CRVS) United States $0.591B 0.00
ACELYRIN, INC (SLRN) United States $0.589B 0.00
Celcuity (CELC) United States $0.587B 0.00
Monte Rosa Therapeutics (GLUE) United States $0.568B 0.00
Alumis (ALMS) United States $0.568B 0.00
Alector (ALEC) United States $0.563B 0.00
Pharming Group (PHAR) Netherlands $0.554B 0.00
REGENXBIO (RGNX) United States $0.553B 0.00
Q32 Bio (QTTB) United States $0.546B 0.00
Aura Biosciences (AURA) United States $0.540B 0.00
Arcturus Therapeutics Holdings (ARCT) United States $0.529B 0.00
Foghorn Therapeutics (FHTX) United States $0.520B 0.00
Terns Pharmaceuticals (TERN) United States $0.513B 0.00
PureTech Health (PRTC) United States $0.499B 0.00
ChromaDex (CDXC) United States $0.496B 650.00
Prime Medicine (PRME) United States $0.492B 0.00
Contineum Therapeutics (CTNM) United States $0.473B 0.00
Ginkgo Bioworks Holdings (DNA) United States $0.472B 0.00
Absci (ABSI) United States $0.462B 0.00
GRAIL (GRAL) United States $0.450B 0.00
MeiraGTx Holdings (MGTX) United States $0.449B 0.00
GH Research (GHRS) Ireland $0.448B 0.00
Cartesian Therapeutics (RNAC) United States $0.444B 0.00
C4 Therapeutics (CCCC) United States $0.428B 0.00
Northwest Biotherapeutics (NWBO) United States $0.395B 0.00
Voyager Therapeutics (VYGR) United States $0.389B 25.46
Revance Therapeutics (RVNC) United States $0.388B 0.00
Alpha Teknova (TKNO) United States $0.382B 0.00
UniQure (QURE) Netherlands $0.380B 0.00
BioStem Technologies (BSEM) $0.379B 58.46
Jasper Therapeutics (JSPR) United States $0.371B 0.00
XOMA Royalty (XOMA) United States $0.362B 0.00
Sutro Biopharma (STRO) United States $0.359B 0.00
MaxCyte (MXCT) United States $0.357B 0.00
EnGene Holdings (ENGN) Canada $0.349B 0.00
Kamada (KMDA) Israel $0.345B 22.22
ITeos Therapeutics (ITOS) United States $0.339B 0.00
Codexis (CDXS) United States $0.332B 0.00
Design Therapeutics (DSGN) United States $0.330B 0.00
Artiva Biotherapeutics (ARTV) United States $0.318B 0.00
Tango Therapeutics (TNGX) United States $0.317B 0.00
AC Immune (ACIU) Switzerland $0.317B 0.00
Mersana Therapeutics (MRSN) United States $0.315B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.313B 0.00
Nautilus Biotechnology (NAUT) United States $0.313B 0.00
Rezolute (RZLT) United States $0.312B 0.00
ProQR Therapeutics (PRQR) Netherlands $0.308B 0.00
Zura Bio (ZURA) United States $0.308B 0.00
TScan Therapeutics (TCRX) United States $0.306B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.303B 0.00
Poseida Therapeutics (PSTX) United States $0.299B 0.00
Biomea Fusion (BMEA) United States $0.296B 0.00
Atea Pharmaceuticals (AVIR) United States $0.295B 0.00
Urogen Pharma (URGN) United States $0.284B 0.00
Ocugen (OCGN) United States $0.284B 0.00
ADC Therapeutics SA (ADCT) Switzerland $0.283B 0.00
Zentalis Pharmaceuticals (ZNTL) United States $0.282B 0.00
Abeona Therapeutics (ABEO) United States $0.277B 0.00
Fate Therapeutics (FATE) United States $0.276B 0.00
Prima BioMed (IMMP) Australia $0.270B 0.00
GENFIT S.A (GNFT) France $0.261B 0.00
Kodiak Sciences (KOD) United States $0.259B 0.00
Inozyme Pharma (INZY) United States $0.258B 0.00
Editas Medicine (EDIT) United States $0.258B 0.00
Climb Bio (CLYM) United States $0.254B 0.00
Anika Therapeutics (ANIK) United States $0.253B 0.00
Lifecore Biomedical (LFCR) United States $0.248B 0.00
Compass Therapeutics (CMPX) United States $0.248B 0.00
Precigen (PGEN) United States $0.247B 0.00
2seventy Bio (TSVT) United States $0.244B 0.00
Caribou Biosciences (CRBU) United States $0.243B 0.00
Opthea (OPT) Australia $0.240B 0.00
ATyr Pharma (ATYR) United States $0.236B 0.00
Amarin (AMRN) Ireland $0.236B 0.00
Inhibrx Biosciences (INBX) United States $0.235B 0.00
Solid Biosciences (SLDB) United States $0.235B 0.00
Orchestra BioMed Holdings (OBIO) United States $0.234B 0.00
XBiotech (XBIT) United States $0.230B 0.00
Kyverna Therapeutics (KYTX) United States $0.228B 0.00
Molecular Partners AG (MOLN) Switzerland $0.228B 0.00
Eton Pharmaceuticals (ETON) United States $0.227B 0.00
Nkarta (NKTX) United States $0.225B 0.00
Trevi Therapeutics (TRVI) United States $0.224B 0.00
Cabaletta Bio (CABA) United States $0.219B 0.00
Fulcrum Therapeutics (FULC) United States $0.218B 0.00
Tenaya Therapeutics (TNYA) United States $0.218B 0.00
ScPharmaceuticals (SCPH) United States $0.210B 0.00
Nuvectis Pharma (NVCT) United States $0.209B 0.00
Semper Paratus Acquisition (TVGN) United States $0.208B 0.00
Bright Minds Biosciences (DRUG) United States $0.207B 0.00
CAMP4 Therapeutics (CAMP) United States $0.207B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $0.204B 0.00
Instil Bio (TIL) United States $0.201B 0.00
Gossamer Bio (GOSS) United States $0.199B 0.00
Acumen Pharmaceuticals (ABOS) United States $0.196B 0.00
Eledon Pharmaceuticals (ELDN) United States $0.192B 0.00
Greenwich LifeSciences (GLSI) United States $0.189B 0.00
Black Diamond Therapeutics (BDTX) United States $0.186B 0.00
DiaMedica Therapeutics (DMAC) United States $0.184B 0.00
Sagimet Biosciences (SGMT) United States $0.182B 0.00
Skye Bioscience (SKYE) United States $0.173B 0.00
Actuate Therapeutics (ACTU) United States $0.171B 0.00
Scilex Holding (SCLX) United States $0.169B 0.00
Adverum Biotechnologies (ADVM) United States $0.166B 0.00
PepGen (PEPG) United States $0.163B 0.00
Verastem (VSTM) United States $0.159B 0.00
Compugen (CGEN) Israel $0.159B 0.00
Akoya Biosciences (AKYA) United States $0.157B 0.00
Ventyx Biosciences (VTYX) United States $0.155B 0.00
Candel Therapeutics (CADL) United States $0.155B 0.00
Repare Therapeutics (RPTX) Canada $0.152B 0.00
Checkpoint Therapeutics (CKPT) United States $0.152B 0.00
Generation Bio (GBIO) United States $0.151B 0.00
Oncobiologics (OTLK) United States $0.150B 0.00
Innate Pharma S.A (IPHA) France $0.149B 0.00
Seer (SEER) United States $0.146B 0.00
Inventiva S.A (IVA) France $0.145B 0.00
Inovio Pharmaceuticals (INO) United States $0.144B 0.00
Cardiff Oncology (CRDF) United States $0.143B 0.00
Vigil Neuroscience (VIGL) United States $0.142B 0.00
Puma Biotechnology (PBYI) United States $0.141B 6.00
INmune Bio (INMB) United States $0.136B 0.00
FibroBiologics (FBLG) United States $0.131B 0.00
Adlai Nortye (ANL) Cayman Islands $0.131B 0.00
Elutia (ELUT) United States $0.129B 0.00
Rani Therapeutics Holdings (RANI) United States $0.129B 0.00
Seres Therapeutics (MCRB) United States $0.122B 0.00
PDS Biotechnology (PDSB) United States $0.121B 0.00
Allakos (ALLK) United States $0.121B 0.00
Coya Therapeutics (COYA) United States $0.120B 0.00
Adherex Technologies (FENC) United States $0.118B 0.00
Adagene (ADAG) China $0.117B 0.00
Alto Neuroscience (ANRO) United States $0.116B 0.00
Invivyd (IVVD) United States $0.115B 0.00
Benitec Biopharma (BNTC) United States $0.112B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.111B 0.00
23andMe Holding (ME) United States $0.110B 0.00
Adicet Bio (ACET) United States $0.108B 0.00
Annovis Bio (ANVS) United States $0.107B 0.00
Immunic (IMUX) United States $0.106B 0.00
Milestone Pharmaceuticals (MIST) Canada $0.105B 0.00
X4 Pharmaceuticals (XFOR) United States $0.104B 0.00
Renovaro (RENB) United States $0.103B 0.00
BioAtla (BCAB) United States $0.102B 0.00
Genelux (GNLX) United States $0.101B 0.00
Rapt Therapeutics (RAPT) United States $0.101B 0.00
Werewolf Therapeutics (HOWL) United States $0.101B 0.00
Cellectis S.A (CLLS) France $0.098B 0.00
Tiziana Life Sciences (TLSA) United Kingdom $0.098B 0.00
HilleVax (HLVX) United States $0.095B 0.00
Cidara Therapeutics (CDTX) United States $0.095B 0.00
Coherus BioSciences (CHRS) United States $0.094B 0.00
Ovid Therapeutics (OVID) United States $0.092B 0.00
BioHarvest Sciences (CNVCF) Canada $0.092B 0.00
InflaRx (IFRX) Germany $0.092B 0.00
Regencell Bioscience Holdings (RGC) Hong Kong, SAR China $0.090B 0.00
I-Mab (IMAB) China $0.090B 0.00
Genenta Science S.p.A (GNTA) Italy $0.089B 0.00
Chimerix (CMRX) United States $0.089B 0.00
Eupraxia Pharmaceuticals (EPRX) Canada $0.088B 0.00
Clearside Biomedical (CLSD) United States $0.085B 0.00
CytomX Therapeutics (CTMX) United States $0.085B 6.41
VistaGen Therapeutics (VTGN) United States $0.085B 0.00
Ikena Oncology (IKNA) United States $0.085B 0.00
Agenus (AGEN) United States $0.084B 0.00
Cue Biopharma (CUE) United States $0.084B 0.00
Leap Therapeutics (LPTX) United States $0.083B 0.00
Oncolytics Biotech (ONCY) Canada $0.082B 0.00
Aileron Therapeutics (ALRN) United States $0.082B 0.00
Galena Biopharma (SLS) United States $0.079B 0.00
Bluebird Bio (BLUE) United States $0.079B 0.00
Aerovate Therapeutics (AVTE) United States $0.079B 0.00
Celularity (CELU) United States $0.078B 0.00
Boundless Bio (BOLD) United States $0.078B 0.00
CervoMed (CRVO) United States $0.077B 0.00
ALX Oncology Holdings (ALXO) United States $0.076B 0.00
TELA Bio (TELA) United States $0.076B 0.00
BeyondSpring (BYSI) United States $0.076B 0.00
MediciNova (MNOV) United States $0.075B 0.00
Quince Therapeutics (QNCX) United States $0.074B 0.00
ZIVO Bioscience (ZIVO) United States $0.073B 0.00
IO Biotech (IOBT) Denmark $0.072B 0.00
Spero Therapeutics (SPRO) United States $0.071B 3.22
Syros Pharmaceuticals (SYRS) United States $0.070B 0.00
Monopar Therapeutics (MNPR) United States $0.067B 0.00
Vor Biopharma (VOR) $0.066B 0.00
DBV Technologies S.A (DBVT) France $0.065B 0.00
Precision BioSciences (DTIL) United States $0.064B 0.00
Connect Biopharma Holdings (CNTB) United States $0.062B 0.00
Entera Bio (ENTX) Israel $0.062B 0.00
Omega Therapeutics (OMGA) United States $0.060B 0.00
Enzo Biochem (ENZ) United States $0.060B 0.00
OnKure Therapeutics (OKUR) United States $0.059B 0.00
Affimed (AFMD) Germany $0.059B 0.00
Theratechnologies (THTX) Canada $0.058B 0.00
Immuneering (IMRX) United States $0.056B 0.00
Shattuck Labs (STTK) United States $0.056B 0.00
Atara Biotherapeutics (ATRA) United States $0.056B 0.00
Elicio Therapeutics (ELTX) United States $0.055B 0.00
Barinthus Biotherapeutics (BRNS) United Kingdom $0.054B 0.00
Kezar Life Sciences (KZR) United States $0.054B 0.00
BGM Group (BGM) China $0.053B 0.00
Aadi Bioscience (AADI) United States $0.052B 0.00
Immix Biopharma (IMMX) United States $0.051B 0.00
Kronos Bio (KRON) United States $0.050B 0.00
Imunon (IMNN) United States $0.048B 0.00
Intensity Therapeutics (INTS) United States $0.045B 0.00
HOOKIPA Pharma (HOOK) United States $0.045B 0.00
CollPlant Biotechnologies (CLGN) Israel $0.045B 0.00
Xilio Therapeutics (XLO) United States $0.044B 0.00
Achilles Therapeutics (ACHL) United Kingdom $0.043B 0.00
Anebulo Pharmaceuticals (ANEB) United States $0.042B 0.00
Prenetics Global (PRE) Hong Kong, SAR China $0.042B 0.00
Rallybio (RLYB) United States $0.041B 0.00
Lantern Pharma (LTRN) United States $0.041B 0.00
VTv Therapeutics (VTVT) United States $0.041B 0.00
Clene (CLNN) United States $0.039B 0.00
Fortress Biotech (FBIO) United States $0.039B 0.00
Elevation Oncology (ELEV) United States $0.038B 0.00
OKYO Pharma (OKYO) $0.038B 0.00
Passage Bio (PASG) United States $0.038B 0.00
Lexaria Bioscience (LEXX) Canada $0.037B 0.00
CalciMedica (CALC) United States $0.037B 0.00
NextCure (NXTC) United States $0.036B 0.00
Dare Bioscience (DARE) United States $0.036B 0.00
Lumos Pharma (LUMO) United States $0.035B 0.00
KALA BIO (KALA) United States $0.035B 0.00
Dyadic (DYAI) United States $0.034B 0.00
AN2 Therapeutics (ANTX) United States $0.033B 0.00
Aligos Therapeutics (ALGS) United States $0.033B 0.00
SAB Biotherapeutics (SABS) United States $0.032B 0.00
Promis Neurosciences (PMN) Canada $0.032B 0.00
Longeveron (LGVN) United States $0.032B 0.00
Eyenovia (EYEN) United States $0.031B 0.00
Acurx Pharmaceuticals (ACXP) United States $0.030B 0.00
Grace Therapeutics (GRCE) Canada $0.030B 0.00
Akari Therapeutics (AKTX) United Kingdom $0.030B 0.00
MiNK Therapeutics (INKT) United States $0.030B 0.00
Opus Genetics (IRD) United States $0.029B 0.00
Ocean Biomedical (OCEA) United States $0.028B 0.00
BioXcel Therapeutics (BTAI) United States $0.028B 0.00
RenovoRx (RNXT) United States $0.027B 0.00
Equillium (EQ) United States $0.027B 0.00
Estrella Immunopharma (ESLA) United States $0.027B 0.00
Curis (CRIS) United States $0.026B 0.00
Athira Pharma (ATHA) United States $0.025B 0.00
CytoMed Therapeutics (GDTC) Singapore $0.025B 0.00
Femasys (FEMY) United States $0.025B 0.00
Pluri (PLUR) Israel $0.025B 0.00
BRIACELL THERAP (BCTX) Canada $0.025B 0.00
Bolt Biotherapeutics (BOLT) United States $0.025B 0.00
Lisata Therapeutics (LSTA) United States $0.024B 0.00
Bionano Genomics (BNGO) United States $0.024B 0.00
MIRA Pharmaceuticals (MIRA) United States $0.023B 0.00
NeuroBo Pharmaceuticals (NRBO) United States $0.023B 0.00
Beyond Air (XAIR) United States $0.022B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.022B 0.00
Spruce Biosciences (SPRB) United States $0.022B 0.00
Gelteq (GELS) $0.022B 0.00
Cyclo Therapeutics (CYTH) United States $0.021B 0.00
Chemomab Therapeutics (CMMB) Israel $0.021B 0.00
Cognition Therapeutics (CGTX) United States $0.020B 0.00
UNITY Biotechnology (UBX) United States $0.020B 0.00
Aprea Therapeutics (APRE) United States $0.019B 0.00
Cadrenal Therapeutics (CVKD) United States $0.019B 0.00
Cara Therapeutics (CARA) United States $0.019B 0.00
LakeShore Biopharma (LSB) China $0.019B 0.00
BioAffinity Technologies (BIAF) United States $0.018B 0.00
Cocrystal Pharma (COCP) United States $0.018B 0.00
NeuroSense Therapeutics (NRSN) Israel $0.018B 0.00
Synlogic (SYBX) United States $0.017B 0.00
GeoVax Labs (GOVX) United States $0.016B 0.00
Tenax Therapeutics (TENX) United States $0.016B 0.00
IN8bio (INAB) United States $0.016B 0.00
Novogen (KZIA) Australia $0.015B 0.00
HCW Biologics (HCWB) United States $0.014B 0.00
Sensei Biotherapeutics (SNSE) United States $0.014B 0.00
Evaxion Biotech (EVAX) Denmark $0.014B 0.00
Apollomics (APLM) United States $0.013B 0.00
COSCIENS Biopharma (CSCI) Canada $0.012B 0.00
Turnstone Biologics (TSBX) United States $0.012B 0.00
Biorestorative Therapies (BRTX) United States $0.011B 0.00
Cingulate (CING) United States $0.011B 0.00
IMMURON (IMRN) Australia $0.010B 0.00
Aytu BioPharma (AYTU) United States $0.010B 0.00
Senti Biosciences (SNTI) United States $0.010B 0.00
Vincerx Pharma (VINC) United States $0.010B 0.00
NKGen Biotech (NKGN) United States $0.010B 0.00
Mustang Bio (MBIO) United States $0.009B 0.00
Evogene (EVGN) Israel $0.009B 0.00
Cardio Diagnostics Holdings (CDIO) United States $0.009B 0.00
Biora Therapeutics (BIOR) United States $0.009B 0.00
Galecto (GLTO) Denmark $0.009B 0.00
Prana Biotechnology (ATHE) Australia $0.008B 0.00
Coeptis Therapeutics Holdings (COEP) United States $0.008B 0.00
Soligenix (SNGX) United States $0.008B 0.00
Edesa Biotech (EDSA) Canada $0.008B 0.00
TuHURA Biosciences (HURA) United States $0.008B 0.00
Pulmatrix (PULM) United States $0.007B 0.00
Forte Biosciences (FBRX) United States $0.007B 0.00
GT Biopharma (GTBP) United States $0.007B 0.00
Quantum Biopharma (QNTM) Canada $0.007B 0.00
Moleculin Biotech (MBRX) United States $0.007B 0.00
Bionomics (BNOX) Australia $0.007B 0.00
Aptose Biosciences (APTO) Canada $0.007B 0.00
Cyclerion Therapeutics (CYCN) United States $0.007B 0.00
Adial Pharmaceuticals (ADIL) United States $0.007B 0.00
ABVC BioPharma (ABVC) United States $0.007B 0.00
Virax Biolabs Group (VRAX) United Kingdom $0.007B 0.00
Ensysce Biosciences (ENSC) United States $0.006B 0.00
Brainstorm Cell Therapeutics (BCLI) United States $0.006B 0.00
Hoth Therapeutics (HOTH) United States $0.006B 0.00
Carmell (CTCX) United States $0.006B 0.00
Organovo Holdings (ONVO) United States $0.006B 0.00
Eterna Therapeutics (ERNA) United States $0.006B 0.00
TFF Pharmaceuticals (TFFP) United States $0.006B 0.00
Alzamend Neuro (ALZN) United States $0.006B 0.00
Silo Pharma (SILO) United States $0.006B 0.00
Vaccinex (VCNX) United States $0.005B 0.00
Polyrizon (PLRZ) $0.005B 0.00
Creative Medical Technology Holdings (CELZ) United States $0.005B 0.00
Psyence Biomedical (PBM) Canada $0.005B 0.00
Portage Biotech (PRTG) $0.005B 0.00
BioCardia (BCDA) United States $0.005B 0.00
Dogwood Therapeutics (DWTX) United States $0.005B 0.00
Exicure (XCUR) United States $0.005B 0.00
Biofrontera (BFRI) United States $0.005B 0.00
Enveric Biosciences (ENVB) United States $0.004B 0.00
AquaBounty Technologies (AQB) United States $0.004B 0.00
GENPREX (GNPX) United States $0.004B 0.00
Synaptogenix (SNPX) United States $0.004B 0.00
Lipella Pharmaceuticals (LIPO) United States $0.004B 0.00
NuCana (NCNA) United Kingdom $0.004B 0.00
CNS Pharmaceuticals (CNSP) United States $0.004B 0.00
Titan Pharmaceuticals (TTNP) United States $0.004B 0.00
Lixte Biotechnology Holdings (LIXT) United States $0.004B 0.00
Purple Biotech (PPBT) Israel $0.004B 0.00
Artelo Biosciences (ARTL) United States $0.004B 0.00
Genetic Technologies (GENE) Australia $0.004B 0.00
Virpax Pharmaceuticals (VRPX) United States $0.004B 0.00
Silexion Therapeutics Corp (SLXN) United States $0.004B 0.00
Hepion Pharmaceuticals (HEPA) United States $0.004B 0.00
Avalon GloboCare (ALBT) United States $0.003B 0.00
Pasithea Therapeutics (KTTA) United States $0.003B 0.00
Palisade Bio (PALI) United States $0.003B 0.00
Sunshine Biopharma (SBFM) United States $0.003B 0.00
Entero Therapeutics (ENTO) United States $0.003B 0.00
NAYA Biosciences (NAYA) United States $0.003B 0.00
Citius Oncology (CTOR) United States $0.003B 0.00
180 Life Sciences (ATNF) United States $0.003B 0.00
Tharimmune (THAR) United States $0.003B 0.00
Atrinsic (PTIX) United States $0.003B 0.00
Aptevo Therapeutics (APVO) United States $0.003B 0.00
GRI Bio (GRI) United States $0.003B 0.00
Bone Biologics (BBLG) United States $0.002B 0.00
Sonnet BioTherapeutics Holdings (SONN) United States $0.002B 0.00
Dermata Therapeutics (DRMA) United States $0.002B 0.00
Scinai Immunotherapeutics (SCNI) Israel $0.002B 0.00
Allarity Therapeutics (ALLR) United States $0.002B 0.00
Onconetix (ONCO) United States $0.002B 0.00
ZyVersa Therapeutics (ZVSA) United States $0.001B 0.00
NeuBase Therapeutics (NBSE) United States $0.001B 0.00
Revelation Biosciences (REVB) United States $0.001B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.001B 0.00
TC BioPharm (Holdings) (TCBP) United Kingdom $0.001B 0.00
Elevai Labs (ELAB) United States $0.000B 0.00
Windtree Therapeutics (WINT) United States $0.000B 0.00
Biodexa Pharmaceuticals (BDRX) United Kingdom $0.000B 0.00
Aceragen (ACGN) United States $0.000B 0.00
Alvotech (ALVO) Luxembourg $0.000B 0.00
ARAVIVE, INC (ARAV) United States $0.000B 0.00
Celyad SA (CYAD) Belgium $0.000B 0.00
LAVA Therapeutics (LVTX) Netherlands $0.000B 0.00
Motif Bio Plc (MTFB) United Kingdom $0.000B 0.00
Mainz Biomed (MYNZ) Germany $0.000B 0.00
PDL BioPharma (PDLI) United States $0.000B 0.00
Pharvaris (PHVS) Netherlands $0.000B 0.00
VectivBio Holding AG (VECT) Switzerland $0.000B 0.00
Clovis Oncology (CLVSQ) United States $0.000B 0.00